| Drug Name: | Chlorphenamine (132-22-9) |
|---|---|
| PubChem ID: | 2725 |
| SMILES: | CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2 |
| InchiKey: | SOYKEARSMXGVTM-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 274.795 |
| LogP | : | 3.8186 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 16.13 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Phenytoin (57-41-0) | Involuntary Jaw Movements | Synergistic | The reason for these reactions is not clear but it has been suggested that chlorphenamine may have inhibited the metabolism of phenytoin by the liver. | Involuntary movements caused by phenytoin intoxication in epileptic patients |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category